Literature DB >> 15012816

Identification method based on PCR combined with automated ribotyping for tracking probiotic Lactobacillus strains colonizing the human gut and vagina.

M Massi1, B Vitali, F Federici, D Matteuzzi, P Brigidi.   

Abstract

AIMS: A molecular methodology based on PCR-associated automated ribotyping was developed to specifically detect the Lactobacillus strains of two probiotic products (an orally administered lyophilized preparation and vaginal tablets) in human faeces and vaginal swabs. METHODS AND
RESULTS: The 16S-23S rDNA sequences and the ribotype profiles of the probiotic lactobacilli were characterized and new species-specific primer sets were designed. The identification of faecal and vaginal lactobacilli isolated from subjects administered with the probiotic products was performed by using PCR with species-specific primers followed by strain-specific automated ribotyping.
CONCLUSIONS: The PCR-ribotyping identification allowed to study the colonization patterns of the probiotic lactobacilli in the human gut and vagina evidencing the strains with the best survival capability. SIGNIFICANCE AND IMPACT OF THE STUDY: The proposed molecular method represents a powerful tool of strain-specific identification, useful for differentiating exogenous from indigenous strains in any microbial ecosystem and for rationally choosing probiotic bacteria with the best chance of survival in the host.

Entities:  

Mesh:

Year:  2004        PMID: 15012816     DOI: 10.1111/j.1365-2672.2004.02228.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  13 in total

1.  Ribotyping of Lactobacillus casei group strains isolated from dairy products.

Authors:  P Svec; V Dráb; I Sedlácek
Journal:  Folia Microbiol (Praha)       Date:  2005       Impact factor: 2.099

2.  Quantitative real-time PCR analysis of fecal Lactobacillus species in infants receiving a prebiotic infant formula.

Authors:  Monique Haarman; Jan Knol
Journal:  Appl Environ Microbiol       Date:  2006-04       Impact factor: 4.792

Review 3.  Safety assessment of probiotics for human use.

Authors:  Mary Ellen Sanders; Louis M A Akkermans; Dirk Haller; Cathy Hammerman; James Heimbach; Gabriele Hörmannsperger; Geert Huys; Dan D Levy; Femke Lutgendorff; David Mack; Phoukham Phothirath; Gloria Solano-Aguilar; Elaine Vaughan
Journal:  Gut Microbes       Date:  2010-03-04

4.  A Method of Direct Quantitation of Lactobacillus spp. in Intestinal Contents Based on Real-Time PCR.

Authors:  Yu M Markova; V V Stetsenko; A S Polyanina
Journal:  Bull Exp Biol Med       Date:  2021-10-28       Impact factor: 0.804

5.  Lactobacillus paragasseri OLL2809 Improves Depression-Like Behavior and Increases Beneficial Gut Microbes in Mice.

Authors:  Narumi Hashikawa-Hobara; Ami Otsuka; Chihiro Okujima; Naoya Hashikawa
Journal:  Front Neurosci       Date:  2022-06-28       Impact factor: 5.152

Review 6.  Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health.

Authors:  Mariya I Petrova; Elke Lievens; Shweta Malik; Nicole Imholz; Sarah Lebeer
Journal:  Front Physiol       Date:  2015-03-25       Impact factor: 4.566

Review 7.  Phenotyping and genotyping are both essential to identify and classify a probiotic microorganism.

Authors:  Gianfranco Donelli; Claudia Vuotto; Paola Mastromarino
Journal:  Microb Ecol Health Dis       Date:  2013-03-11

8.  Novel approaches for the taxonomic and metabolic characterization of lactobacilli: Integration of 16S rRNA gene sequencing with MALDI-TOF MS and 1H-NMR.

Authors:  Claudio Foschi; Luca Laghi; Carola Parolin; Barbara Giordani; Monica Compri; Roberto Cevenini; Antonella Marangoni; Beatrice Vitali
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

9.  Quantitative Detection of Bifidobacterium longum Strains in Feces Using Strain-Specific Primers.

Authors:  Yue Xiao; Chen Wang; Jianxin Zhao; Hao Zhang; Wei Chen; Qixiao Zhai
Journal:  Microorganisms       Date:  2021-05-28

10.  Comparative genomic analysis of the multispecies probiotic-marketed product VSL#3.

Authors:  François P Douillard; Diego Mora; Robyn T Eijlander; Michiel Wels; Willem M de Vos
Journal:  PLoS One       Date:  2018-02-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.